Evidence map›Paper›PMID 28660467›Full record

SynthesisInternational journal of clinical pharmacy2017

Influence of dexmedetomidine on cardiac complications in non-cardiac surgery: a meta-analysis of randomized trials.

Shuan Jin, Xueyue Zhou

Abstract readMeta-Analysis
PubMed Publisher
In one paragraph

Synthesis in International journal of clinical pharmacy, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 13 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Response to letter to the editor.Journal of anesthesia · 2019
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Shuan JinDepartment of Anesthesia, Jinan Central Hospital Affiliated to Shandong University, Shandong Province, Jinan, 250013, China. jinshuanzxyy@163.com.
Xueyue ZhouMedical Center Tsinghua University, Beijing, 100084, China.
Shandong University · CNTsinghua University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background The cardiac protection of dexmedetomidine (Dex) in peri-operative period of patients with non-cardiac surgery is still controversial. Aim of the Review We aimed to evaluate the influence of Dex on cardiac complications in peri-operative period of non-cardiac surgery by using a meta-analysis. Methods PubMed, Embase, the Cochrane library and Springer databases were searched for relevant studies. Patients in the eligible studies were divided into Dex group and placebo group. Relative risk (RR) and the 95 % confidence interval (CI) were calculated to evaluate the outcomes including all-cause mortality, myocardial infarction, myocardial ischaemia, hypotension and bradycardia. Subgroup analysis was performed based on the dosage of Dex. Publication bias was assessed by Egger's test. Results Twenty double-blind randomized controlled trials containing 1157 patients were included in this meta-analysis. The pooled results showed no significant difference between Dex group and placebo group in peri-operative myocardial infarction, myocardial ischaemia and all-cause mortality. However, Dex group showed higher risk of hypotension (RR = 1.46, 95 % CI 1.07, 2.01) and bradycardia (RR = 1.98, 95 % CI 1.33, 2.95) than that of placebo group. In addition, significant publication bias was found among studies involving hypotension and bradycardia. In subgroup analysis, the risk of bradycardia was significantly higher in 1.0 μg/kg Dex group than that in placebo group. Besides, a higher risk of hypotension in 0.5 μg/kg Dex group than that in placebo group was found. Conclusions Dex supplement might not reduce the risk of cardiac complications but increases the risk of hypotension and bradycardia in peri-operative period of patients who underwent non-cardiac surgeries.

Indexed as

Adrenergic alpha-2 Receptor AgonistsBradycardiaDexmedetomidineHeart DiseasesHumansHypotensionMortalityPostoperative ComplicationsRandomized Controlled Trials as TopicAdrenergic alpha-2 Receptor AgonistsDexmedetomidineDexmedetomidineNon-cardiac surgeryPeri-operative cardiac complications

Identifiers

PMID28660467
OpenAlexW2727148973

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.